As of April, 2026, Withings has been accepted into the CMS ACCESS program.
We will be participating in both the Early Cardio-Kidney-Metabolic (eCKM) and Cardio-Kidney-Metabolic (CKM) clinical tracks across all 50 states and will begin enrolling Medicare beneficiaries when ACCESS launches on July 5, 2026.
ACCESS represents a meaningful step forward for Medicare, introducing outcome-aligned payment and patient choice into chronic care at national scale. Withings commends the CMS Innovation Center for creating a framework that rewards innovation, quality, and transparency, and is proud to participate from day one.
For all questions on insurance coverage and qualifications, please contact CMS ACCESS here.
A New Standard for the Patient Experience in Medicare
For the first time, Medicare beneficiaries can choose their own program to manage their chronic conditions. That changes the equation: delivering a premium care experience becomes central to earning and retaining patient participation.
"Withings has been building for this moment for over a decade with over 15 million users, more than 1 million patients actively monitored, and 28 CES Innovation Awards. We bring the combination that ACCESS demands: devices patients want to use every day, a physician-supervised clinical program, and EHR integrations that keep patients connected to the care team they know and trust." said Patrick Sheehan, Vice President of Value-Based Care, Withings.
A Commitment to Affordable, High-Quality Care
Withings is dedicated to helping build a high-quality, affordable healthcare system. Every Medicare beneficiary deserves a premium care experience regardless of their ability to pay. Withings will waive all beneficiary cost-sharing under the ACCESS Model, ensuring patients can participate at no out-of-pocket cost, without changing their care team, and without disrupting their existing Medicare coverage.
An Integrated Care Experience for Patients and Their Care Teams
Withings will offer an integrated program that strengthens the relationship between the patient and their care team. For health systems and ACOs, this means their patients get access to continuous care between visits and their clinicians get a trusted partner in managing their patients' chronic conditions.
A Connected Device Partner for Other ACCESS Participants
Withings will also make its connected device ecosystem available through the ACCESS Tools Directory, enabling other ACCESS participants to leverage the same FDA-cleared, cellular-enabled devices in their own programs. This includes BPM Pro 2, a cellular blood pressure monitor engineered for value-based care, combining the capture of both clinical measurements and patient-reported outcomes at the point of reading.
More information about the partnership can be found
here.